nodes	percent_of_prediction	percent_of_DWPC	metapath
Deferiprone—UGT1A6—Estrogen metabolism—SULT1A1—breast cancer	0.0108	0.0339	CbGpPWpGaD
Deferiprone—UGT1A6—Estrogen metabolism—GSTA1—breast cancer	0.0106	0.0331	CbGpPWpGaD
Deferiprone—UGT1A6—Aryl Hydrocarbon Receptor Pathway—ALDH3A1—breast cancer	0.0101	0.0316	CbGpPWpGaD
Deferiprone—UGT1A6—Aryl Hydrocarbon Receptor Pathway—SERPINB2—breast cancer	0.00701	0.0219	CbGpPWpGaD
Deferiprone—UGT1A6—Constitutive Androstane Receptor Pathway—GSTA2—breast cancer	0.00692	0.0217	CbGpPWpGaD
Deferiprone—UGT1A6—Constitutive Androstane Receptor Pathway—SULT1A1—breast cancer	0.00684	0.0214	CbGpPWpGaD
Deferiprone—UGT1A6—Estrogen metabolism—NQO1—breast cancer	0.00674	0.0211	CbGpPWpGaD
Deferiprone—UGT1A6—Estrogen metabolism—CYP3A4—breast cancer	0.00658	0.0206	CbGpPWpGaD
Deferiprone—UGT1A6—Estrogen metabolism—CYP1B1—breast cancer	0.00647	0.0202	CbGpPWpGaD
Deferiprone—UGT1A6—Estrogen metabolism—COMT—breast cancer	0.00565	0.0177	CbGpPWpGaD
Deferiprone—UGT1A6—Aryl Hydrocarbon Receptor Pathway—GSTA2—breast cancer	0.00518	0.0162	CbGpPWpGaD
Deferiprone—UGT1A6—Estrogen metabolism—GSTM1—breast cancer	0.00517	0.0162	CbGpPWpGaD
Deferiprone—UGT1A6—Estrogen metabolism—CYP1A1—breast cancer	0.0049	0.0153	CbGpPWpGaD
Deferiprone—UGT1A6—Constitutive Androstane Receptor Pathway—NCOA2—breast cancer	0.00462	0.0145	CbGpPWpGaD
Deferiprone—UGT1A6—Aryl Hydrocarbon Receptor Pathway—AHR—breast cancer	0.00452	0.0141	CbGpPWpGaD
Deferiprone—UGT1A6—Oxidative Stress—NQO1—breast cancer	0.00448	0.014	CbGpPWpGaD
Deferiprone—UGT1A6—NRF2 pathway—SLC2A10—breast cancer	0.00432	0.0135	CbGpPWpGaD
Deferiprone—UGT1A6—Constitutive Androstane Receptor Pathway—CYP3A4—breast cancer	0.00415	0.013	CbGpPWpGaD
Deferiprone—UGT1A6—NRF2 pathway—ALDH3A1—breast cancer	0.00402	0.0126	CbGpPWpGaD
Deferiprone—UGT1A6—Constitutive Androstane Receptor Pathway—HSP90AA1—breast cancer	0.004	0.0125	CbGpPWpGaD
Deferiprone—UGT1A6—Constitutive Androstane Receptor Pathway—NCOA1—breast cancer	0.00389	0.0122	CbGpPWpGaD
Deferiprone—UGT1A6—Oxidative Stress—HMOX1—breast cancer	0.00369	0.0115	CbGpPWpGaD
Deferiprone—UGT1A6—NRF2 pathway—SLC39A7—breast cancer	0.00358	0.0112	CbGpPWpGaD
Deferiprone—UGT1A6—Phase II conjugation—GSTA3—breast cancer	0.00346	0.0108	CbGpPWpGaD
Deferiprone—UGT1A6—Oxidative Stress—SOD2—breast cancer	0.00345	0.0108	CbGpPWpGaD
Deferiprone—UGT1A6—Constitutive Androstane Receptor Pathway—ABCB1—breast cancer	0.00336	0.0105	CbGpPWpGaD
Deferiprone—UGT1A6—Oxidative Stress—GPX1—breast cancer	0.00329	0.0103	CbGpPWpGaD
Deferiprone—UGT1A6—Metapathway biotransformation—CHST9—breast cancer	0.00327	0.0102	CbGpPWpGaD
Deferiprone—UGT1A6—Oxidative Stress—CYP1A1—breast cancer	0.00326	0.0102	CbGpPWpGaD
Deferiprone—UGT1A6—Aryl Hydrocarbon Receptor Pathway—NQO1—breast cancer	0.00318	0.00996	CbGpPWpGaD
Deferiprone—UGT1A6—Phase II conjugation—GSTA4—breast cancer	0.00316	0.00989	CbGpPWpGaD
Deferiprone—UGT1A6—NRF2 pathway—SLC2A5—breast cancer	0.00315	0.00986	CbGpPWpGaD
Deferiprone—UGT1A6—Phase II conjugation—GSTA2—breast cancer	0.00308	0.00964	CbGpPWpGaD
Deferiprone—UGT1A6—Aryl Hydrocarbon Receptor Pathway—CYP1B1—breast cancer	0.00305	0.00955	CbGpPWpGaD
Deferiprone—UGT1A6—Phase II conjugation—SULT1A1—breast cancer	0.00304	0.00952	CbGpPWpGaD
Deferiprone—UGT1A6—Aryl Hydrocarbon Receptor Pathway—HSP90AA1—breast cancer	0.00299	0.00936	CbGpPWpGaD
Deferiprone—UGT1A6—Phase II conjugation—GSTA1—breast cancer	0.00297	0.0093	CbGpPWpGaD
Deferiprone—UGT1A6—Phase II conjugation—NAT2—breast cancer	0.00294	0.0092	CbGpPWpGaD
Deferiprone—UGT1A6—Aryl Hydrocarbon Receptor Pathway—NCOA1—breast cancer	0.00291	0.00911	CbGpPWpGaD
Deferiprone—UGT1A6—NRF2 pathway—SLC39A6—breast cancer	0.00271	0.00849	CbGpPWpGaD
Deferiprone—UGT1A6—Aryl Hydrocarbon Receptor Pathway—HES1—breast cancer	0.00245	0.00768	CbGpPWpGaD
Deferiprone—UGT1A6—Oxidative Stress—FOS—breast cancer	0.00243	0.00761	CbGpPWpGaD
Deferiprone—UGT1A6—Phase II conjugation—MTR—breast cancer	0.0024	0.0075	CbGpPWpGaD
Deferiprone—UGT1A6—Aryl Hydrocarbon Receptor Pathway—BAX—breast cancer	0.00238	0.00744	CbGpPWpGaD
Deferiprone—UGT1A6—Phase II conjugation—HPGDS—breast cancer	0.00235	0.00735	CbGpPWpGaD
Deferiprone—UGT1A6—Aryl Hydrocarbon Receptor Pathway—CYP1A1—breast cancer	0.00231	0.00724	CbGpPWpGaD
Deferiprone—UGT1A6—NRF2 pathway—GSTA3—breast cancer	0.00231	0.00721	CbGpPWpGaD
Deferiprone—UGT1A6—Phase II conjugation—GSTT1—breast cancer	0.00228	0.00713	CbGpPWpGaD
Deferiprone—UGT1A6—Biological oxidations—ALDH1A1—breast cancer	0.00227	0.0071	CbGpPWpGaD
Deferiprone—UGT1A6—NRF2 pathway—GSTA4—breast cancer	0.00211	0.0066	CbGpPWpGaD
Deferiprone—UGT1A6—NRF2 pathway—GSTA2—breast cancer	0.00206	0.00643	CbGpPWpGaD
Deferiprone—UGT1A6—NRF2 pathway—GPX2—breast cancer	0.00206	0.00643	CbGpPWpGaD
Deferiprone—UGT1A6—Biological oxidations—GSTA3—breast cancer	0.00202	0.00633	CbGpPWpGaD
Deferiprone—UGT1A6—Metapathway biotransformation—GSTA3—breast cancer	0.002	0.00624	CbGpPWpGaD
Deferiprone—UGT1A6—NRF2 pathway—GSTA1—breast cancer	0.00198	0.0062	CbGpPWpGaD
Deferiprone—UGT1A6—Biological oxidations—GSTA4—breast cancer	0.00185	0.00579	CbGpPWpGaD
Deferiprone—UGT1A6—Metapathway biotransformation—GSTA4—breast cancer	0.00182	0.00571	CbGpPWpGaD
Deferiprone—UGT1A6—Biological oxidations—GSTA2—breast cancer	0.0018	0.00564	CbGpPWpGaD
Deferiprone—UGT1A6—Biological oxidations—SULT1A1—breast cancer	0.00178	0.00557	CbGpPWpGaD
Deferiprone—UGT1A6—Metapathway biotransformation—GPX2—breast cancer	0.00178	0.00556	CbGpPWpGaD
Deferiprone—UGT1A6—Metapathway biotransformation—GPX4—breast cancer	0.00176	0.00549	CbGpPWpGaD
Deferiprone—UGT1A6—Metapathway biotransformation—SULT1A1—breast cancer	0.00176	0.00549	CbGpPWpGaD
Deferiprone—UGT1A6—Biological oxidations—GSTA1—breast cancer	0.00174	0.00544	CbGpPWpGaD
Deferiprone—UGT1A6—Biological oxidations—NAT2—breast cancer	0.00172	0.00538	CbGpPWpGaD
Deferiprone—UGT1A6—Metapathway biotransformation—NAT2—breast cancer	0.0017	0.00531	CbGpPWpGaD
Deferiprone—UGT1A6—NRF2 pathway—SLC2A2—breast cancer	0.00163	0.0051	CbGpPWpGaD
Deferiprone—UGT1A6—Phase II conjugation—COMT—breast cancer	0.00159	0.00497	CbGpPWpGaD
Deferiprone—UGT1A6—Phase II conjugation—GSTP1—breast cancer	0.00158	0.00494	CbGpPWpGaD
Deferiprone—UGT1A6—Phase II conjugation—GSTM1—breast cancer	0.00145	0.00454	CbGpPWpGaD
Deferiprone—UGT1A6—Aryl Hydrocarbon Receptor Pathway—IFNG—breast cancer	0.00143	0.00449	CbGpPWpGaD
Deferiprone—UGT1A6—NRF2 pathway—TGFB2—breast cancer	0.00142	0.00446	CbGpPWpGaD
Deferiprone—UGT1A6—Biological oxidations—MTR—breast cancer	0.0014	0.00439	CbGpPWpGaD
Deferiprone—UGT1A6—Biological oxidations—HPGDS—breast cancer	0.00138	0.0043	CbGpPWpGaD
Deferiprone—UGT1A6—NRF2 pathway—SQSTM1—breast cancer	0.00135	0.00422	CbGpPWpGaD
Deferiprone—UGT1A6—Biological oxidations—GSTT1—breast cancer	0.00133	0.00417	CbGpPWpGaD
Deferiprone—UGT1A6—NRF2 pathway—SLC5A5—breast cancer	0.00131	0.00409	CbGpPWpGaD
Deferiprone—UGT1A6—Aryl Hydrocarbon Receptor Pathway—CDKN1B—breast cancer	0.0013	0.00408	CbGpPWpGaD
Deferiprone—UGT1A6—Aryl Hydrocarbon Receptor Pathway—IL1B—breast cancer	0.00128	0.004	CbGpPWpGaD
Deferiprone—UGT1A6—Aryl Hydrocarbon Receptor Pathway—IL2—breast cancer	0.00128	0.00399	CbGpPWpGaD
Deferiprone—UGT1A6—NRF2 pathway—SLC2A1—breast cancer	0.00126	0.00395	CbGpPWpGaD
Deferiprone—UGT1A6—NRF2 pathway—NQO1—breast cancer	0.00126	0.00395	CbGpPWpGaD
Deferiprone—UGT1A6—Biological oxidations—CYP17A1—breast cancer	0.00126	0.00395	CbGpPWpGaD
Deferiprone—UGT1A6—Biological oxidations—PTGS1—breast cancer	0.00125	0.00391	CbGpPWpGaD
Deferiprone—UGT1A6—Metapathway biotransformation—CYP17A1—breast cancer	0.00125	0.0039	CbGpPWpGaD
Deferiprone—UGT1A6—Aryl Hydrocarbon Receptor Pathway—JUN—breast cancer	0.00124	0.00388	CbGpPWpGaD
Deferiprone—UGT1A6—Biological oxidations—CYP2D6—breast cancer	0.00123	0.00383	CbGpPWpGaD
Deferiprone—UGT1A6—Metapathway biotransformation—CYP2D6—breast cancer	0.00121	0.00378	CbGpPWpGaD
Deferiprone—UGT1A6—Biological oxidations—NCOA2—breast cancer	0.0012	0.00376	CbGpPWpGaD
Deferiprone—UGT1A6—NRF2 pathway—HSP90AA1—breast cancer	0.00119	0.00372	CbGpPWpGaD
Deferiprone—UGT1A6—NRF2 pathway—EGR1—breast cancer	0.00117	0.00367	CbGpPWpGaD
Deferiprone—UGT1A6—Aryl Hydrocarbon Receptor Pathway—SRC—breast cancer	0.00111	0.00348	CbGpPWpGaD
Deferiprone—UGT1A6—Biological oxidations—CYP3A4—breast cancer	0.00108	0.00338	CbGpPWpGaD
Deferiprone—UGT1A6—Metapathway biotransformation—CYP3A4—breast cancer	0.00107	0.00333	CbGpPWpGaD
Deferiprone—UGT1A6—Biological oxidations—CYP1B1—breast cancer	0.00106	0.00332	CbGpPWpGaD
Deferiprone—UGT1A6—NRF2 pathway—TGFBR2—breast cancer	0.00105	0.0033	CbGpPWpGaD
Deferiprone—UGT1A6—NRF2 pathway—GSTP1—breast cancer	0.00105	0.0033	CbGpPWpGaD
Deferiprone—UGT1A6—Metapathway biotransformation—CYP1B1—breast cancer	0.00105	0.00328	CbGpPWpGaD
Deferiprone—UGT1A6—NRF2 pathway—HMOX1—breast cancer	0.00104	0.00325	CbGpPWpGaD
Deferiprone—UGT1A6—Biological oxidations—NCOA1—breast cancer	0.00101	0.00317	CbGpPWpGaD
Deferiprone—UGT1A6—Biological oxidations—CYP19A1—breast cancer	0.000999	0.00313	CbGpPWpGaD
Deferiprone—UGT1A6—Aryl Hydrocarbon Receptor Pathway—TGFB1—breast cancer	0.000995	0.00311	CbGpPWpGaD
Deferiprone—UGT1A6—Metapathway biotransformation—CYP19A1—breast cancer	0.000985	0.00308	CbGpPWpGaD
Deferiprone—UGT1A6—Aryl Hydrocarbon Receptor Pathway—EGFR—breast cancer	0.000975	0.00305	CbGpPWpGaD
Deferiprone—UGT1A6—NRF2 pathway—HGF—breast cancer	0.000969	0.00303	CbGpPWpGaD
Deferiprone—UGT1A6—NRF2 pathway—GSTM1—breast cancer	0.000969	0.00303	CbGpPWpGaD
Deferiprone—UGT1A6—NRF2 pathway—NRG1—breast cancer	0.000951	0.00297	CbGpPWpGaD
Deferiprone—UGT1A6—Biological oxidations—COMT—breast cancer	0.000929	0.00291	CbGpPWpGaD
Deferiprone—UGT1A6—Aryl Hydrocarbon Receptor Pathway—TNF—breast cancer	0.000929	0.00291	CbGpPWpGaD
Deferiprone—UGT1A6—Biological oxidations—GSTP1—breast cancer	0.000924	0.00289	CbGpPWpGaD
Deferiprone—UGT1A6—Metapathway biotransformation—COMT—breast cancer	0.000916	0.00287	CbGpPWpGaD
Deferiprone—UGT1A6—Metapathway biotransformation—GSTP1—breast cancer	0.000912	0.00285	CbGpPWpGaD
Deferiprone—UGT1A6—Biological oxidations—GSTM1—breast cancer	0.00085	0.00266	CbGpPWpGaD
Deferiprone—UGT1A6—Metapathway biotransformation—GSTM1—breast cancer	0.000838	0.00262	CbGpPWpGaD
Deferiprone—UGT1A6—Biological oxidations—CYP1A1—breast cancer	0.000805	0.00252	CbGpPWpGaD
Deferiprone—UGT1A6—Metapathway biotransformation—CYP1A1—breast cancer	0.000794	0.00248	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—SYNJ2—breast cancer	0.000648	0.00203	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—NDUFS3—breast cancer	0.000602	0.00188	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—CHST9—breast cancer	0.000566	0.00177	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—COX11—breast cancer	0.000537	0.00168	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—CDA—breast cancer	0.000491	0.00154	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—SHMT1—breast cancer	0.000491	0.00154	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—SLCO1B1—breast cancer	0.000473	0.00148	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—SLC2A5—breast cancer	0.000473	0.00148	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—APRT—breast cancer	0.000457	0.00143	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—ESRRA—breast cancer	0.000429	0.00134	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—ANGPTL4—breast cancer	0.000429	0.00134	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—GPI—breast cancer	0.000407	0.00127	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—HADHB—breast cancer	0.000407	0.00127	CbGpPWpGaD
Deferiprone—UGT1A6—NRF2 pathway—TGFB1—breast cancer	0.000395	0.00123	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—ALDH7A1—breast cancer	0.000388	0.00121	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—ALDH1A1—breast cancer	0.000388	0.00121	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—UMPS—breast cancer	0.000372	0.00116	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—FHL2—breast cancer	0.000372	0.00116	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—NME1—breast cancer	0.000372	0.00116	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—ADSL—breast cancer	0.000372	0.00116	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—PHGDH—breast cancer	0.000372	0.00116	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—HPSE—breast cancer	0.000365	0.00114	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—BRIP1—breast cancer	0.000365	0.00114	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—LDHB—breast cancer	0.000365	0.00114	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—HMMR—breast cancer	0.000346	0.00108	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—GSTA3—breast cancer	0.000346	0.00108	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—ABCC1—breast cancer	0.000346	0.00108	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—PPARGC1B—breast cancer	0.000335	0.00105	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—CA9—breast cancer	0.000316	0.00099	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—GSTA4—breast cancer	0.000316	0.00099	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—GPX2—breast cancer	0.000308	0.000965	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—GSTA2—breast cancer	0.000308	0.000965	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—SULT1A1—breast cancer	0.000305	0.000953	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—GPX4—breast cancer	0.000305	0.000953	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—IDH1—breast cancer	0.000298	0.000931	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—GSTA1—breast cancer	0.000298	0.000931	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—NAT2—breast cancer	0.000294	0.00092	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—DPYD—breast cancer	0.000258	0.000807	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—MED12—breast cancer	0.000258	0.000807	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—ALDOA—breast cancer	0.000254	0.000794	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—NCOA3—breast cancer	0.000247	0.000771	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—SLC2A2—breast cancer	0.000245	0.000766	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—CPT1A—breast cancer	0.00024	0.00075	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—MTR—breast cancer	0.00024	0.00075	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—ABCG2—breast cancer	0.00024	0.00075	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—HPGDS—breast cancer	0.000235	0.000736	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—HBA1—breast cancer	0.000234	0.000731	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—GSTT1—breast cancer	0.000228	0.000714	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—ACHE—breast cancer	0.000228	0.000714	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—CYP17A1—breast cancer	0.000216	0.000675	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—PTGS1—breast cancer	0.000214	0.000669	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—ENO1—breast cancer	0.000214	0.000669	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—CYP2D6—breast cancer	0.00021	0.000656	CbGpPWpGaD
Deferiprone—Asthenia—Irinotecan—breast cancer	0.000206	0.000303	CcSEcCtD
Deferiprone—Asthenia—Mitoxantrone—breast cancer	0.000206	0.000303	CcSEcCtD
Deferiprone—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—breast cancer	0.000206	0.000303	CcSEcCtD
Deferiprone—UGT1A6—Metabolism—NCOA2—breast cancer	0.000206	0.000644	CbGpPWpGaD
Deferiprone—Jaundice—Epirubicin—breast cancer	0.000205	0.000301	CcSEcCtD
Deferiprone—Neutropenia—Doxorubicin—breast cancer	0.000204	0.0003	CcSEcCtD
Deferiprone—Decreased appetite—Paclitaxel—breast cancer	0.000204	0.0003	CcSEcCtD
Deferiprone—Hypertension—Capecitabine—breast cancer	0.000204	0.000299	CcSEcCtD
Deferiprone—Hypersensitivity—Fluorouracil—breast cancer	0.000203	0.000298	CcSEcCtD
Deferiprone—Gastrointestinal disorder—Paclitaxel—breast cancer	0.000202	0.000298	CcSEcCtD
Deferiprone—Fatigue—Paclitaxel—breast cancer	0.000202	0.000297	CcSEcCtD
Deferiprone—Hepatitis—Methotrexate—breast cancer	0.000202	0.000296	CcSEcCtD
Deferiprone—Asthenia—Gemcitabine—breast cancer	0.000201	0.000295	CcSEcCtD
Deferiprone—Arthralgia—Capecitabine—breast cancer	0.000201	0.000295	CcSEcCtD
Deferiprone—Pain—Paclitaxel—breast cancer	0.000201	0.000295	CcSEcCtD
Deferiprone—Pharyngitis—Methotrexate—breast cancer	0.0002	0.000294	CcSEcCtD
Deferiprone—UGT1A6—Metabolism—FASN—breast cancer	0.0002	0.000624	CbGpPWpGaD
Deferiprone—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—breast cancer	0.000199	0.000293	CcSEcCtD
Deferiprone—Urinary tract disorder—Methotrexate—breast cancer	0.000199	0.000293	CcSEcCtD
Deferiprone—Photosensitivity reaction—Doxorubicin—breast cancer	0.000199	0.000293	CcSEcCtD
Deferiprone—Hepatobiliary disease—Epirubicin—breast cancer	0.000199	0.000292	CcSEcCtD
Deferiprone—Anaphylactic shock—Docetaxel—breast cancer	0.000199	0.000292	CcSEcCtD
Deferiprone—UGT1A6—Metabolism—BCHE—breast cancer	0.000199	0.000622	CbGpPWpGaD
Deferiprone—Weight increased—Doxorubicin—breast cancer	0.000199	0.000292	CcSEcCtD
Deferiprone—Discomfort—Capecitabine—breast cancer	0.000198	0.000292	CcSEcCtD
Deferiprone—Epistaxis—Epirubicin—breast cancer	0.000198	0.000291	CcSEcCtD
Deferiprone—Pruritus—Gemcitabine—breast cancer	0.000198	0.000291	CcSEcCtD
Deferiprone—Nausea—Thiotepa—breast cancer	0.000198	0.000291	CcSEcCtD
Deferiprone—Urethral disorder—Methotrexate—breast cancer	0.000198	0.000291	CcSEcCtD
Deferiprone—Infection—Docetaxel—breast cancer	0.000198	0.00029	CcSEcCtD
Deferiprone—Diarrhoea—Irinotecan—breast cancer	0.000197	0.000289	CcSEcCtD
Deferiprone—Diarrhoea—Mitoxantrone—breast cancer	0.000197	0.000289	CcSEcCtD
Deferiprone—UGT1A6—Metabolism—SLC5A5—breast cancer	0.000196	0.000614	CbGpPWpGaD
Deferiprone—Agranulocytosis—Epirubicin—breast cancer	0.000196	0.000288	CcSEcCtD
Deferiprone—Pneumonia—Doxorubicin—breast cancer	0.000196	0.000288	CcSEcCtD
Deferiprone—Nervous system disorder—Docetaxel—breast cancer	0.000195	0.000287	CcSEcCtD
Deferiprone—Pruritus—Fluorouracil—breast cancer	0.000195	0.000286	CcSEcCtD
Deferiprone—Infestation—Doxorubicin—breast cancer	0.000195	0.000286	CcSEcCtD
Deferiprone—Infestation NOS—Doxorubicin—breast cancer	0.000195	0.000286	CcSEcCtD
Deferiprone—Skin disorder—Docetaxel—breast cancer	0.000193	0.000284	CcSEcCtD
Deferiprone—Gastrointestinal pain—Paclitaxel—breast cancer	0.000192	0.000282	CcSEcCtD
Deferiprone—Diarrhoea—Gemcitabine—breast cancer	0.000192	0.000282	CcSEcCtD
Deferiprone—Infection—Capecitabine—breast cancer	0.000191	0.000281	CcSEcCtD
Deferiprone—Jaundice—Doxorubicin—breast cancer	0.00019	0.000279	CcSEcCtD
Deferiprone—UGT1A6—Metabolism—SLC2A1—breast cancer	0.00019	0.000593	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—NQO1—breast cancer	0.00019	0.000593	CbGpPWpGaD
Deferiprone—Nervous system disorder—Capecitabine—breast cancer	0.000189	0.000277	CcSEcCtD
Deferiprone—Hepatitis—Epirubicin—breast cancer	0.000189	0.000277	CcSEcCtD
Deferiprone—Eye disorder—Methotrexate—breast cancer	0.000188	0.000277	CcSEcCtD
Deferiprone—Diarrhoea—Fluorouracil—breast cancer	0.000188	0.000277	CcSEcCtD
Deferiprone—Pharyngitis—Epirubicin—breast cancer	0.000187	0.000275	CcSEcCtD
Deferiprone—Cardiac disorder—Methotrexate—breast cancer	0.000187	0.000275	CcSEcCtD
Deferiprone—Skin disorder—Capecitabine—breast cancer	0.000187	0.000275	CcSEcCtD
Deferiprone—Urinary tract disorder—Epirubicin—breast cancer	0.000186	0.000274	CcSEcCtD
Deferiprone—Urticaria—Paclitaxel—breast cancer	0.000186	0.000274	CcSEcCtD
Deferiprone—Hyperhidrosis—Capecitabine—breast cancer	0.000186	0.000274	CcSEcCtD
Deferiprone—Oedema peripheral—Epirubicin—breast cancer	0.000186	0.000273	CcSEcCtD
Deferiprone—Hypotension—Docetaxel—breast cancer	0.000186	0.000273	CcSEcCtD
Deferiprone—Connective tissue disorder—Epirubicin—breast cancer	0.000185	0.000273	CcSEcCtD
Deferiprone—Body temperature increased—Paclitaxel—breast cancer	0.000185	0.000273	CcSEcCtD
Deferiprone—Abdominal pain—Paclitaxel—breast cancer	0.000185	0.000273	CcSEcCtD
Deferiprone—Urethral disorder—Epirubicin—breast cancer	0.000185	0.000272	CcSEcCtD
Deferiprone—UGT1A6—Metabolism—CYP3A4—breast cancer	0.000185	0.000578	CbGpPWpGaD
Deferiprone—Hepatobiliary disease—Doxorubicin—breast cancer	0.000184	0.00027	CcSEcCtD
Deferiprone—Epistaxis—Doxorubicin—breast cancer	0.000183	0.00027	CcSEcCtD
Deferiprone—Angiopathy—Methotrexate—breast cancer	0.000183	0.000269	CcSEcCtD
Deferiprone—Vomiting—Mitoxantrone—breast cancer	0.000183	0.000269	CcSEcCtD
Deferiprone—Vomiting—Irinotecan—breast cancer	0.000183	0.000269	CcSEcCtD
Deferiprone—Immune system disorder—Methotrexate—breast cancer	0.000182	0.000268	CcSEcCtD
Deferiprone—Mediastinal disorder—Methotrexate—breast cancer	0.000182	0.000267	CcSEcCtD
Deferiprone—UGT1A6—Metabolism—CYP1B1—breast cancer	0.000182	0.000569	CbGpPWpGaD
Deferiprone—Agranulocytosis—Doxorubicin—breast cancer	0.000182	0.000267	CcSEcCtD
Deferiprone—Rash—Irinotecan—breast cancer	0.000181	0.000267	CcSEcCtD
Deferiprone—Rash—Mitoxantrone—breast cancer	0.000181	0.000267	CcSEcCtD
Deferiprone—Dermatitis—Mitoxantrone—breast cancer	0.000181	0.000266	CcSEcCtD
Deferiprone—Dermatitis—Irinotecan—breast cancer	0.000181	0.000266	CcSEcCtD
Deferiprone—Musculoskeletal discomfort—Docetaxel—breast cancer	0.000181	0.000266	CcSEcCtD
Deferiprone—Chills—Methotrexate—breast cancer	0.000181	0.000266	CcSEcCtD
Deferiprone—Headache—Mitoxantrone—breast cancer	0.00018	0.000265	CcSEcCtD
Deferiprone—Headache—Irinotecan—breast cancer	0.00018	0.000265	CcSEcCtD
Deferiprone—Hypotension—Capecitabine—breast cancer	0.00018	0.000264	CcSEcCtD
Deferiprone—UGT1A6—Metabolism—HSP90AA1—breast cancer	0.000178	0.000558	CbGpPWpGaD
Deferiprone—Vomiting—Gemcitabine—breast cancer	0.000178	0.000262	CcSEcCtD
Deferiprone—Somnolence—Docetaxel—breast cancer	0.000177	0.00026	CcSEcCtD
Deferiprone—Mental disorder—Methotrexate—breast cancer	0.000177	0.00026	CcSEcCtD
Deferiprone—Rash—Gemcitabine—breast cancer	0.000177	0.00026	CcSEcCtD
Deferiprone—Dermatitis—Gemcitabine—breast cancer	0.000176	0.000259	CcSEcCtD
Deferiprone—Eye disorder—Epirubicin—breast cancer	0.000176	0.000259	CcSEcCtD
Deferiprone—Malnutrition—Methotrexate—breast cancer	0.000176	0.000258	CcSEcCtD
Deferiprone—Headache—Gemcitabine—breast cancer	0.000175	0.000258	CcSEcCtD
Deferiprone—Musculoskeletal discomfort—Capecitabine—breast cancer	0.000175	0.000258	CcSEcCtD
Deferiprone—Cardiac disorder—Epirubicin—breast cancer	0.000175	0.000257	CcSEcCtD
Deferiprone—Vomiting—Fluorouracil—breast cancer	0.000175	0.000257	CcSEcCtD
Deferiprone—Dyspepsia—Docetaxel—breast cancer	0.000175	0.000257	CcSEcCtD
Deferiprone—Hepatitis—Doxorubicin—breast cancer	0.000175	0.000257	CcSEcCtD
Deferiprone—Rash—Fluorouracil—breast cancer	0.000174	0.000255	CcSEcCtD
Deferiprone—Dermatitis—Fluorouracil—breast cancer	0.000174	0.000255	CcSEcCtD
Deferiprone—UGT1A6—Metabolism—NCOA1—breast cancer	0.000173	0.000542	CbGpPWpGaD
Deferiprone—Pharyngitis—Doxorubicin—breast cancer	0.000173	0.000255	CcSEcCtD
Deferiprone—Decreased appetite—Docetaxel—breast cancer	0.000173	0.000254	CcSEcCtD
Deferiprone—Hypersensitivity—Paclitaxel—breast cancer	0.000173	0.000254	CcSEcCtD
Deferiprone—Headache—Fluorouracil—breast cancer	0.000173	0.000254	CcSEcCtD
Deferiprone—Urinary tract disorder—Doxorubicin—breast cancer	0.000172	0.000254	CcSEcCtD
Deferiprone—Oedema peripheral—Doxorubicin—breast cancer	0.000172	0.000253	CcSEcCtD
Deferiprone—Gastrointestinal disorder—Docetaxel—breast cancer	0.000172	0.000252	CcSEcCtD
Deferiprone—Connective tissue disorder—Doxorubicin—breast cancer	0.000172	0.000252	CcSEcCtD
Deferiprone—Fatigue—Docetaxel—breast cancer	0.000171	0.000252	CcSEcCtD
Deferiprone—Angiopathy—Epirubicin—breast cancer	0.000171	0.000252	CcSEcCtD
Deferiprone—Urethral disorder—Doxorubicin—breast cancer	0.000171	0.000252	CcSEcCtD
Deferiprone—UGT1A6—Metabolism—STK11—breast cancer	0.000171	0.000535	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—CYP19A1—breast cancer	0.000171	0.000535	CbGpPWpGaD
Deferiprone—Nausea—Irinotecan—breast cancer	0.000171	0.000251	CcSEcCtD
Deferiprone—Nausea—Mitoxantrone—breast cancer	0.000171	0.000251	CcSEcCtD
Deferiprone—Immune system disorder—Epirubicin—breast cancer	0.00017	0.000251	CcSEcCtD
Deferiprone—Mediastinal disorder—Epirubicin—breast cancer	0.00017	0.00025	CcSEcCtD
Deferiprone—Pain—Docetaxel—breast cancer	0.00017	0.00025	CcSEcCtD
Deferiprone—Back pain—Methotrexate—breast cancer	0.00017	0.00025	CcSEcCtD
Deferiprone—Dyspepsia—Capecitabine—breast cancer	0.000169	0.000249	CcSEcCtD
Deferiprone—Chills—Epirubicin—breast cancer	0.000169	0.000249	CcSEcCtD
Deferiprone—Asthenia—Paclitaxel—breast cancer	0.000168	0.000247	CcSEcCtD
Deferiprone—Decreased appetite—Capecitabine—breast cancer	0.000167	0.000246	CcSEcCtD
Deferiprone—Nausea—Gemcitabine—breast cancer	0.000166	0.000245	CcSEcCtD
Deferiprone—Gastrointestinal disorder—Capecitabine—breast cancer	0.000166	0.000244	CcSEcCtD
Deferiprone—Fatigue—Capecitabine—breast cancer	0.000166	0.000244	CcSEcCtD
Deferiprone—Pruritus—Paclitaxel—breast cancer	0.000166	0.000244	CcSEcCtD
Deferiprone—Mental disorder—Epirubicin—breast cancer	0.000165	0.000243	CcSEcCtD
Deferiprone—Pain—Capecitabine—breast cancer	0.000165	0.000242	CcSEcCtD
Deferiprone—Malnutrition—Epirubicin—breast cancer	0.000164	0.000242	CcSEcCtD
Deferiprone—Nausea—Fluorouracil—breast cancer	0.000164	0.00024	CcSEcCtD
Deferiprone—Eye disorder—Doxorubicin—breast cancer	0.000163	0.00024	CcSEcCtD
Deferiprone—Gastrointestinal pain—Docetaxel—breast cancer	0.000163	0.000239	CcSEcCtD
Deferiprone—Cardiac disorder—Doxorubicin—breast cancer	0.000162	0.000238	CcSEcCtD
Deferiprone—Diarrhoea—Paclitaxel—breast cancer	0.00016	0.000236	CcSEcCtD
Deferiprone—Back pain—Epirubicin—breast cancer	0.000159	0.000234	CcSEcCtD
Deferiprone—UGT1A6—Metabolism—COMT—breast cancer	0.000159	0.000497	CbGpPWpGaD
Deferiprone—Angiopathy—Doxorubicin—breast cancer	0.000158	0.000233	CcSEcCtD
Deferiprone—UGT1A6—Metabolism—GSTP1—breast cancer	0.000158	0.000495	CbGpPWpGaD
Deferiprone—Immune system disorder—Doxorubicin—breast cancer	0.000158	0.000232	CcSEcCtD
Deferiprone—Gastrointestinal pain—Capecitabine—breast cancer	0.000157	0.000231	CcSEcCtD
Deferiprone—Mediastinal disorder—Doxorubicin—breast cancer	0.000157	0.000231	CcSEcCtD
Deferiprone—Abdominal pain—Docetaxel—breast cancer	0.000157	0.000231	CcSEcCtD
Deferiprone—Body temperature increased—Docetaxel—breast cancer	0.000157	0.000231	CcSEcCtD
Deferiprone—Chills—Doxorubicin—breast cancer	0.000157	0.00023	CcSEcCtD
Deferiprone—UGT1A6—Metabolism—HMOX1—breast cancer	0.000156	0.000488	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—ITPR1—breast cancer	0.000156	0.000487	CbGpPWpGaD
Deferiprone—Mental disorder—Doxorubicin—breast cancer	0.000153	0.000225	CcSEcCtD
Deferiprone—Urticaria—Capecitabine—breast cancer	0.000153	0.000225	CcSEcCtD
Deferiprone—Abdominal pain—Capecitabine—breast cancer	0.000152	0.000224	CcSEcCtD
Deferiprone—Body temperature increased—Capecitabine—breast cancer	0.000152	0.000224	CcSEcCtD
Deferiprone—Convulsion—Methotrexate—breast cancer	0.000152	0.000224	CcSEcCtD
Deferiprone—Malnutrition—Doxorubicin—breast cancer	0.000152	0.000223	CcSEcCtD
Deferiprone—UGT1A6—Metabolism—ABCB1—breast cancer	0.00015	0.000468	CbGpPWpGaD
Deferiprone—Arthralgia—Methotrexate—breast cancer	0.000149	0.00022	CcSEcCtD
Deferiprone—Vomiting—Paclitaxel—breast cancer	0.000149	0.000219	CcSEcCtD
Deferiprone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	0.000148	0.000218	CcSEcCtD
Deferiprone—Rash—Paclitaxel—breast cancer	0.000148	0.000217	CcSEcCtD
Deferiprone—Dermatitis—Paclitaxel—breast cancer	0.000148	0.000217	CcSEcCtD
Deferiprone—Discomfort—Methotrexate—breast cancer	0.000148	0.000217	CcSEcCtD
Deferiprone—Back pain—Doxorubicin—breast cancer	0.000147	0.000216	CcSEcCtD
Deferiprone—UGT1A6—Metabolism—TYMS—breast cancer	0.000147	0.00046	CbGpPWpGaD
Deferiprone—Headache—Paclitaxel—breast cancer	0.000147	0.000216	CcSEcCtD
Deferiprone—Hypersensitivity—Docetaxel—breast cancer	0.000146	0.000215	CcSEcCtD
Deferiprone—UGT1A6—Metabolism—PLA2G4A—breast cancer	0.000145	0.000454	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—NCOR1—breast cancer	0.000145	0.000454	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—GSTM1—breast cancer	0.000145	0.000454	CbGpPWpGaD
Deferiprone—Anaphylactic shock—Methotrexate—breast cancer	0.000143	0.000211	CcSEcCtD
Deferiprone—Asthenia—Docetaxel—breast cancer	0.000143	0.00021	CcSEcCtD
Deferiprone—Convulsion—Epirubicin—breast cancer	0.000142	0.000209	CcSEcCtD
Deferiprone—Infection—Methotrexate—breast cancer	0.000142	0.000209	CcSEcCtD
Deferiprone—Hypertension—Epirubicin—breast cancer	0.000142	0.000209	CcSEcCtD
Deferiprone—Hypersensitivity—Capecitabine—breast cancer	0.000142	0.000208	CcSEcCtD
Deferiprone—Pruritus—Docetaxel—breast cancer	0.000141	0.000207	CcSEcCtD
Deferiprone—Nervous system disorder—Methotrexate—breast cancer	0.000141	0.000207	CcSEcCtD
Deferiprone—Arthralgia—Epirubicin—breast cancer	0.00014	0.000206	CcSEcCtD
Deferiprone—Nausea—Paclitaxel—breast cancer	0.000139	0.000205	CcSEcCtD
Deferiprone—Skin disorder—Methotrexate—breast cancer	0.000139	0.000205	CcSEcCtD
Deferiprone—UGT1A6—Metabolism—GPX1—breast cancer	0.000139	0.000435	CbGpPWpGaD
Deferiprone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	0.000139	0.000204	CcSEcCtD
Deferiprone—Hyperhidrosis—Methotrexate—breast cancer	0.000139	0.000204	CcSEcCtD
Deferiprone—Discomfort—Epirubicin—breast cancer	0.000138	0.000203	CcSEcCtD
Deferiprone—Asthenia—Capecitabine—breast cancer	0.000138	0.000203	CcSEcCtD
Deferiprone—UGT1A6—Metabolism—CYP1A1—breast cancer	0.000138	0.000431	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—ERCC2—breast cancer	0.000137	0.000427	CbGpPWpGaD
Deferiprone—Pruritus—Capecitabine—breast cancer	0.000136	0.0002	CcSEcCtD
Deferiprone—Diarrhoea—Docetaxel—breast cancer	0.000136	0.0002	CcSEcCtD
Deferiprone—Anaphylactic shock—Epirubicin—breast cancer	0.000134	0.000197	CcSEcCtD
Deferiprone—Hypotension—Methotrexate—breast cancer	0.000134	0.000197	CcSEcCtD
Deferiprone—Infection—Epirubicin—breast cancer	0.000133	0.000196	CcSEcCtD
Deferiprone—Convulsion—Doxorubicin—breast cancer	0.000132	0.000194	CcSEcCtD
Deferiprone—Diarrhoea—Capecitabine—breast cancer	0.000132	0.000194	CcSEcCtD
Deferiprone—Nervous system disorder—Epirubicin—breast cancer	0.000132	0.000193	CcSEcCtD
Deferiprone—Hypertension—Doxorubicin—breast cancer	0.000131	0.000193	CcSEcCtD
Deferiprone—Musculoskeletal discomfort—Methotrexate—breast cancer	0.000131	0.000192	CcSEcCtD
Deferiprone—Skin disorder—Epirubicin—breast cancer	0.00013	0.000191	CcSEcCtD
Deferiprone—Hyperhidrosis—Epirubicin—breast cancer	0.00013	0.000191	CcSEcCtD
Deferiprone—Arthralgia—Doxorubicin—breast cancer	0.000129	0.00019	CcSEcCtD
Deferiprone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	0.000129	0.000189	CcSEcCtD
Deferiprone—UGT1A6—Metabolism—MTHFR—breast cancer	0.000128	0.000402	CbGpPWpGaD
Deferiprone—Discomfort—Doxorubicin—breast cancer	0.000128	0.000188	CcSEcCtD
Deferiprone—Somnolence—Methotrexate—breast cancer	0.000127	0.000187	CcSEcCtD
Deferiprone—Vomiting—Docetaxel—breast cancer	0.000126	0.000186	CcSEcCtD
Deferiprone—Dyspepsia—Methotrexate—breast cancer	0.000126	0.000185	CcSEcCtD
Deferiprone—Rash—Docetaxel—breast cancer	0.000125	0.000184	CcSEcCtD
Deferiprone—Hypotension—Epirubicin—breast cancer	0.000125	0.000184	CcSEcCtD
Deferiprone—Dermatitis—Docetaxel—breast cancer	0.000125	0.000184	CcSEcCtD
Deferiprone—Decreased appetite—Methotrexate—breast cancer	0.000125	0.000183	CcSEcCtD
Deferiprone—Headache—Docetaxel—breast cancer	0.000125	0.000183	CcSEcCtD
Deferiprone—Anaphylactic shock—Doxorubicin—breast cancer	0.000124	0.000182	CcSEcCtD
Deferiprone—Gastrointestinal disorder—Methotrexate—breast cancer	0.000124	0.000182	CcSEcCtD
Deferiprone—Fatigue—Methotrexate—breast cancer	0.000124	0.000182	CcSEcCtD
Deferiprone—Infection—Doxorubicin—breast cancer	0.000123	0.000181	CcSEcCtD
Deferiprone—Pain—Methotrexate—breast cancer	0.000123	0.00018	CcSEcCtD
Deferiprone—Vomiting—Capecitabine—breast cancer	0.000122	0.00018	CcSEcCtD
Deferiprone—Musculoskeletal discomfort—Epirubicin—breast cancer	0.000122	0.00018	CcSEcCtD
Deferiprone—Nervous system disorder—Doxorubicin—breast cancer	0.000122	0.000179	CcSEcCtD
Deferiprone—Rash—Capecitabine—breast cancer	0.000121	0.000178	CcSEcCtD
Deferiprone—Dermatitis—Capecitabine—breast cancer	0.000121	0.000178	CcSEcCtD
Deferiprone—Headache—Capecitabine—breast cancer	0.000121	0.000177	CcSEcCtD
Deferiprone—Skin disorder—Doxorubicin—breast cancer	0.000121	0.000177	CcSEcCtD
Deferiprone—Hyperhidrosis—Doxorubicin—breast cancer	0.00012	0.000176	CcSEcCtD
Deferiprone—Somnolence—Epirubicin—breast cancer	0.000119	0.000175	CcSEcCtD
Deferiprone—UGT1A6—Metabolism—CAV1—breast cancer	0.000118	0.00037	CbGpPWpGaD
Deferiprone—Nausea—Docetaxel—breast cancer	0.000118	0.000174	CcSEcCtD
Deferiprone—Dyspepsia—Epirubicin—breast cancer	0.000118	0.000173	CcSEcCtD
Deferiprone—Gastrointestinal pain—Methotrexate—breast cancer	0.000117	0.000172	CcSEcCtD
Deferiprone—Decreased appetite—Epirubicin—breast cancer	0.000117	0.000171	CcSEcCtD
Deferiprone—Hypotension—Doxorubicin—breast cancer	0.000116	0.00017	CcSEcCtD
Deferiprone—Gastrointestinal disorder—Epirubicin—breast cancer	0.000116	0.00017	CcSEcCtD
Deferiprone—Fatigue—Epirubicin—breast cancer	0.000116	0.00017	CcSEcCtD
Deferiprone—Pain—Epirubicin—breast cancer	0.000115	0.000169	CcSEcCtD
Deferiprone—Nausea—Capecitabine—breast cancer	0.000114	0.000168	CcSEcCtD
Deferiprone—Urticaria—Methotrexate—breast cancer	0.000114	0.000167	CcSEcCtD
Deferiprone—Abdominal pain—Methotrexate—breast cancer	0.000113	0.000166	CcSEcCtD
Deferiprone—Body temperature increased—Methotrexate—breast cancer	0.000113	0.000166	CcSEcCtD
Deferiprone—Musculoskeletal discomfort—Doxorubicin—breast cancer	0.000113	0.000166	CcSEcCtD
Deferiprone—Somnolence—Doxorubicin—breast cancer	0.00011	0.000162	CcSEcCtD
Deferiprone—Gastrointestinal pain—Epirubicin—breast cancer	0.00011	0.000161	CcSEcCtD
Deferiprone—Dyspepsia—Doxorubicin—breast cancer	0.000109	0.000161	CcSEcCtD
Deferiprone—UGT1A6—Metabolism—PIK3CG—breast cancer	0.000108	0.000337	CbGpPWpGaD
Deferiprone—Decreased appetite—Doxorubicin—breast cancer	0.000108	0.000159	CcSEcCtD
Deferiprone—Gastrointestinal disorder—Doxorubicin—breast cancer	0.000107	0.000157	CcSEcCtD
Deferiprone—Fatigue—Doxorubicin—breast cancer	0.000107	0.000157	CcSEcCtD
Deferiprone—Urticaria—Epirubicin—breast cancer	0.000107	0.000157	CcSEcCtD
Deferiprone—Pain—Doxorubicin—breast cancer	0.000106	0.000156	CcSEcCtD
Deferiprone—Body temperature increased—Epirubicin—breast cancer	0.000106	0.000156	CcSEcCtD
Deferiprone—Abdominal pain—Epirubicin—breast cancer	0.000106	0.000156	CcSEcCtD
Deferiprone—Hypersensitivity—Methotrexate—breast cancer	0.000106	0.000155	CcSEcCtD
Deferiprone—Asthenia—Methotrexate—breast cancer	0.000103	0.000151	CcSEcCtD
Deferiprone—Gastrointestinal pain—Doxorubicin—breast cancer	0.000101	0.000149	CcSEcCtD
Deferiprone—Pruritus—Methotrexate—breast cancer	0.000101	0.000149	CcSEcCtD
Deferiprone—Hypersensitivity—Epirubicin—breast cancer	9.88e-05	0.000145	CcSEcCtD
Deferiprone—Urticaria—Doxorubicin—breast cancer	9.86e-05	0.000145	CcSEcCtD
Deferiprone—Body temperature increased—Doxorubicin—breast cancer	9.81e-05	0.000144	CcSEcCtD
Deferiprone—Abdominal pain—Doxorubicin—breast cancer	9.81e-05	0.000144	CcSEcCtD
Deferiprone—Diarrhoea—Methotrexate—breast cancer	9.8e-05	0.000144	CcSEcCtD
Deferiprone—Asthenia—Epirubicin—breast cancer	9.62e-05	0.000141	CcSEcCtD
Deferiprone—Pruritus—Epirubicin—breast cancer	9.49e-05	0.000139	CcSEcCtD
Deferiprone—UGT1A6—Metabolism—PIK3CD—breast cancer	9.48e-05	0.000297	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—ALB—breast cancer	9.36e-05	0.000293	CbGpPWpGaD
Deferiprone—Diarrhoea—Epirubicin—breast cancer	9.17e-05	0.000135	CcSEcCtD
Deferiprone—Hypersensitivity—Doxorubicin—breast cancer	9.14e-05	0.000134	CcSEcCtD
Deferiprone—Vomiting—Methotrexate—breast cancer	9.11e-05	0.000134	CcSEcCtD
Deferiprone—Rash—Methotrexate—breast cancer	9.03e-05	0.000133	CcSEcCtD
Deferiprone—Dermatitis—Methotrexate—breast cancer	9.03e-05	0.000133	CcSEcCtD
Deferiprone—Headache—Methotrexate—breast cancer	8.98e-05	0.000132	CcSEcCtD
Deferiprone—UGT1A6—Metabolism—NOS3—breast cancer	8.96e-05	0.00028	CbGpPWpGaD
Deferiprone—Asthenia—Doxorubicin—breast cancer	8.9e-05	0.000131	CcSEcCtD
Deferiprone—Pruritus—Doxorubicin—breast cancer	8.78e-05	0.000129	CcSEcCtD
Deferiprone—Vomiting—Epirubicin—breast cancer	8.53e-05	0.000125	CcSEcCtD
Deferiprone—Nausea—Methotrexate—breast cancer	8.51e-05	0.000125	CcSEcCtD
Deferiprone—Diarrhoea—Doxorubicin—breast cancer	8.49e-05	0.000125	CcSEcCtD
Deferiprone—Rash—Epirubicin—breast cancer	8.45e-05	0.000124	CcSEcCtD
Deferiprone—Dermatitis—Epirubicin—breast cancer	8.45e-05	0.000124	CcSEcCtD
Deferiprone—Headache—Epirubicin—breast cancer	8.4e-05	0.000123	CcSEcCtD
Deferiprone—UGT1A6—Metabolism—PIK3CB—breast cancer	8.27e-05	0.000259	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—PTGS2—breast cancer	8.19e-05	0.000256	CbGpPWpGaD
Deferiprone—Nausea—Epirubicin—breast cancer	7.96e-05	0.000117	CcSEcCtD
Deferiprone—Vomiting—Doxorubicin—breast cancer	7.89e-05	0.000116	CcSEcCtD
Deferiprone—Rash—Doxorubicin—breast cancer	7.82e-05	0.000115	CcSEcCtD
Deferiprone—Dermatitis—Doxorubicin—breast cancer	7.82e-05	0.000115	CcSEcCtD
Deferiprone—Headache—Doxorubicin—breast cancer	7.77e-05	0.000114	CcSEcCtD
Deferiprone—Nausea—Doxorubicin—breast cancer	7.37e-05	0.000108	CcSEcCtD
Deferiprone—UGT1A6—Metabolism—PTEN—breast cancer	7.14e-05	0.000223	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—PIK3CA—breast cancer	5.04e-05	0.000158	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—AKT1—breast cancer	4.12e-05	0.000129	CbGpPWpGaD
